Gamma vinyl GABA
RxNorm 14851
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 14851 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Gamma vinyl GABA.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Gamma vinyl GABA
(Atom ID: 2064616)
SYPrescribable
Synonym (SY):
Gamma vinyl gamma aminobutyric acid
(Atom ID: 2064617)
FNPrescribable
Full form of descriptor (FN):
Product containing vigabatrin (medicinal product)
(Atom ID: 9263991)
INPrescribable
Ingredient (IN):
Vigabatrin
(Atom ID: 12253387)
PTPrescribable
Designated preferred name (PT):
Vigabatrin
(Atom ID: 2858312)
FNPrescribable
Full form of descriptor (FN):
Vigabatrin (substance)
(Atom ID: 2858313)
PTPrescribable
Designated preferred name (PT):
Vigabatrin-containing product
(Atom ID: 10822595)
Patient Education
Vigabatrin
Vigabatrin tablets are used in combination with other medications to control certain types of seizures in adults and children 10 years of age or older whose seizures were not controlled by several other medications. Vigabatrin powder is used to control infantile spasms (a type of seizure that babies and children can have) in babies 1 month to 2 years of age. Vigabatrin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.